Kawaguchi, K., Miyake, K., Han, Q., Li, S., Tan, Y., Igarashi, K., . . . Hoffman, R. M. (2018). Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer. Cell Cycle.
Chicago-стиль цитированияKawaguchi, Kei, et al. "Targeting Altered Cancer Methionine Metabolism With Recombinant Methioninase (rMETase) Overcomes Partial Gemcitabine-resistance and Regresses a Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Pancreatic Cancer." Cell Cycle 2018.
MLA-цитированиеKawaguchi, Kei, et al. "Targeting Altered Cancer Methionine Metabolism With Recombinant Methioninase (rMETase) Overcomes Partial Gemcitabine-resistance and Regresses a Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Pancreatic Cancer." Cell Cycle 2018.